$PARS PHARMOS CORP Insider Trading
Get free email notifications about insider trading in PHARMOS CORP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in PHARMOS CORP. Insider overview, share value development, latest insider transactions and email notifications about new events in PHARMOS CORP for free.
CIK Number: 0000713275
IRS Number: 363207413
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: PARS
Company Address: 3609 HAMMERKOP DR. NORTH LAS VEGAS 89084
Former name: PHARMATEC INC, date of change: 1992-07-03
Market Capitalization: $1.11M
Prev close: $0.02
Average Daily Volume: 13,968
Days Low: $0.02
Year Low: $0.00
Year High: $0.05
PHARMOS CORP Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jul 05 2012 | PARS | PHARMOS CORP | Leventer Steven | Director | Option Exercise | A | 0.08 | 20,000 | 1,600 | 20,000 | |
Jul 03 2012 | PARS | PHARMOS CORP | EVNIN ANTHONY B | Director | Option Exercise | A | 0.08 | 25,000 | 2,000 | 25,000 | |
Jul 03 2012 | PARS | PHARMOS CORP | NEWHALL CHARLES W III | Director | Option Exercise | A | 0.08 | 25,000 | 2,000 | 25,000 | |
Jan 11 2012 | PARS | PHARMOS CORP | EVNIN ANTHONY B | Director | Option Exercise | A | 0.06 | 25,000 | 1,500 | 25,000 | |
Jan 10 2012 | PARS | PHARMOS CORP | NEWHALL CHARLES W III | Director | Option Exercise | A | 0.06 | 25,000 | 1,500 | 25,000 | |
Jan 10 2012 | PARS | PHARMOS CORP | Leventer Steven | Director | Option Exercise | A | 0.06 | 20,000 | 1,200 | 20,000 | |
Jul 06 2011 | PARS | PHARMOS CORP | EVNIN ANTHONY B | Director | Option Exercise | A | 0.13 | 25,000 | 3,250 | 25,000 | |
Jul 06 2011 | PARS | PHARMOS CORP | NEWHALL CHARLES W III | Director | Option Exercise | A | 0.13 | 25,000 | 3,250 | 25,000 | |
Mar 30 2011 | PARS | PHARMOS CORP | NEILL SYDNEY COLIN | President and CFO | Option Exercise | A | 0.09 | 400,000 | 36,000 | 400,000 | |
Mar 30 2011 | PARS | PHARMOS CORP | Leventer Steven | Director | Option Exercise | A | 0.09 | 50,000 | 4,500 | 50,000 | |
Mar 30 2011 | PARS | PHARMOS CORP | Johnston Robert F | Executive Chairman | Option Exercise | A | 0.09 | 300,000 | 27,000 | 300,000 | |
Mar 30 2011 | PARS | PHARMOS CORP | Johnston Robert F | Executive Chairman | Buy | P | 0.09 | 3,628 | 327 | 11,946,271 | 11.9 M to 11.9 M (+0.03 %) |
Mar 22 2011 | PARS | PHARMOS CORP | Johnston Robert F | Executive Chairman | Buy | P | 0.09 | 81,708 | 7,354 | 11,933,644 | 11.9 M to 11.9 M (+0.69 %) |
Mar 25 2011 | PARS | PHARMOS CORP | Johnston Robert F | Executive Chairman | Buy | P | 0.09 | 8,999 | 810 | 11,942,643 | 11.9 M to 11.9 M (+0.08 %) |
Mar 22 2011 | PARS | PHARMOS CORP | Johnston Robert F | Executive Chairman | Buy | P | 0.09 | 57,015 | 5,131 | 11,851,936 | 11.8 M to 11.9 M (+0.48 %) |